
Endocrinology/Hormones
Endocrinology/hormone inhibitors are compounds that block the action of hormones or interfere with hormone signaling pathways. These inhibitors are essential for studying the regulation of endocrine systems and for developing treatments for hormone-related diseases, such as diabetes, thyroid disorders, and hormone-dependent cancers. By modulating hormone activity, these inhibitors can help elucidate the complex interactions within the endocrine system. At CymitQuimica, we offer a wide range of high-quality endocrinology/hormone inhibitors to support your research in endocrinology, pharmacology, and medical sciences.
Subcategories of "Endocrinology/Hormones"
- Androgen Receptor(207 products)
- Annexin A(11 products)
- Aromatase(20 products)
- Estrogen/progestogen Receptor(49 products)
- GPR(1 products)
- Glucocorticoid Receptor(153 products)
- LHRH(1 products)
- Opioid Receptor(296 products)
- Prostaglandin Receptor(119 products)
- RAAS(86 products)
- Reductase(52 products)
- Somatostatin(46 products)
- Thyroid hormone receptor(THR)(26 products)
- Vasopressin Receptor(44 products)
Show 6 more subcategories
Found 3178 products of "Endocrinology/Hormones"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
PD 123177
CAS:<p>PD 123177 is an inhibitor of Nonpeptide angiotensin AII-2.</p>Formula:C29H28N4O3Purity:98%Color and Shape:SolidMolecular weight:480.56Ac-RYYRIK-NH2
CAS:<p>NOP site high affinity ligand (Ki=1.5 nM); blocks nociceptin effects in rat brain/heart; agonist in vivo, reduces mouse movement.</p>Formula:C44H70N14O9Purity:98%Color and Shape:SolidMolecular weight:939.12OX04528
CAS:<p>OX04528 is an orally active and potent GPR84 biased agonist.OX04528 inhibits cAMP signaling and may be useful in cancer research.</p>Formula:C16H13F6NO2Purity:99.74%Color and Shape:SoildMolecular weight:365.27Raloxifene 4'-glucuronide
CAS:<p>Raloxifene 4'-glucuronide is a primary metabolite of Raloxifene.</p>Formula:C34H35NO10SPurity:98%Color and Shape:SolidMolecular weight:649.71Antitumor agent-195
<p>Antitumor agent-195 (compound 16c) is a dual-targeting agent that simultaneously targets STAT3 and NQO1. At a concentration of 1 μM, it significantly inhibits the phosphorylation of STAT3 at the Tyr705 site and effectively induces apoptosis in MDA-MB-231 and MDA-MB-468 breast cancer cells. As a substrate of NQO1, Antitumor agent-195 markedly increases ROS production, causing severe DNA damage in a dose-dependent manner. It also demonstrates strong antitumor properties in MDA-MB-231 xenograft models.</p>Formula:C22H22N2O4Color and Shape:SolidMolecular weight:378.42Axelopran
CAS:<p>Axelopran (TD-1211) treats opioid constipation; it's a potent, selective peripheral opioid blocker.</p>Formula:C26H39N3O4Color and Shape:SolidMolecular weight:457.61PD 125967
CAS:<p>PD 125967 is a renin inhibitor, which represents a group of pharmaceutical drugs used primarily to treat essential hypertension.</p>Formula:C51H67N5O4Color and Shape:SolidMolecular weight:814.11Nocistatin
CAS:<p>Nocistatin, a neuropeptide, blocks Nociceptin effects and inhibits 5-HT release, acting on an opioid-related receptor.</p>Formula:C32H56N10O12Color and Shape:SolidMolecular weight:772.85[Orn8]-Urotensin II
CAS:<p>[Orn8]-Urotensin II is a Urotensin receptor ligand and a partial agonist at Urotensin receptors.</p>Formula:C63H83N13O18S2Color and Shape:SolidMolecular weight:1374.55Cgp 44099
CAS:<p>Cgp 44099 is a potent plasma renin inhibitor from all subprimate species.</p>Formula:C69H104N14O13Purity:98%Color and Shape:SolidMolecular weight:1337.676Alunacedase alfa
CAS:<p>Alunacedase alfa (APN-01) is an angiotensin-converting enzyme 2 with antiviral activity.</p>Purity:99.1% (SDS-PAGE); 99.9% (SEC-HPLC) - 99.1% (SDS-PAGE); 99.9% (SEC-HPLC)Color and Shape:Liquid(rel)-PROTAC ERRα Degrader-1
<p>(rel)-PROTAC ERRα Degrader-1 is a relative configuration of PROTAC ERRα Degrader-1, which is an estrogen-related receptor alpha (ERRa) degrader.</p>Formula:C54H49Cl2F6N7O8Purity:98%Color and Shape:SolidMolecular weight:1108.91HINT1-IN-1
<p>HINT1-IN-1 (compound 8) is an inhibitor of histidine triad nucleotide-binding protein 1 (HINT1) with a Ki of 1.14 μM. It influences the cross-regulation between μ-opioid receptors (MOR) and NMDA receptors (NMDAR).</p>Formula:C23H24N8O5Color and Shape:SolidMolecular weight:492.49PROTAC ER Degrader-4
CAS:<p>PROTAC ER Degrader-4 is a PROATC degrader of estrogen receptor (ER)(IC50 of 0.8 nM).</p>Formula:C53H67F3N6O8SPurity:98%Color and Shape:SolidMolecular weight:1005.2PTP1B/AKR1B1-IN-1
<p>PTP1B/AKR1B1-IN-1 is a dual inhibitor targeting protein tyrosine phosphatase 1B (PTP1B) and aldose reductase (AKR1B1), exhibiting inhibitory potency with IC50s</p>Formula:C22H21NO4S2Purity:98%Color and Shape:SolidMolecular weight:427.54SNIPER(ER)-110
<p>SNIPER(ER)-110 links cIAP1 and estrogen ligands. SNIPER(ER)-51 degrades ER protein; DC50 <3 nM at 4h, 7.7 nM at 48h.</p>Formula:C66H83N5O11Purity:98%Color and Shape:SolidMolecular weight:1122.39ST-CY14
<p>ST-CY14 is an inhibitor of the Nur77-PPARγ interaction with an EC50 of 3.15 μM. It binds to Nur77 (Kd=32 nM) to prevent its ubiquitination and degradation by PPARγ, reducing fatty acid uptake and mitochondrial respiration, and inhibiting the transcription of CD36 and FABP4. ST-CY14 suppresses proliferation and migration of MCF7 and MDA-MB-231 cancer cells and impedes tumor growth and bone metastasis in mouse models.</p>Formula:C139H237N57O31S2Color and Shape:SolidMolecular weight:3266.86DAMGO (TFA)
CAS:<p>DAMGO is a selective peptide agonist of the µ-opioid receptor .</p>Formula:C28H36F3N5O8Purity:98%Color and Shape:SolidMolecular weight:627.61OT-R antagonist 2
CAS:<p>OT-R antagonist 2 is a nonpeptide low molecular weight antagonist of OT-R .</p>Formula:C28H29N3O4Purity:98%Color and Shape:SolidMolecular weight:471.55(d(CH2)51,Tyr(Me)2,Orn8)-Oxytocin
CAS:<p>(d(CH2)51,Tyr(Me)2, Orn8)-Oxytocin (OVT) is an antagonist of the oxytocin receptor that finds application in the study of neurological diseases [1].</p>Formula:C48H74N12O12S2Purity:98%Color and Shape:SolidMolecular weight:1075.3

